Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy

Hemorrhagic infarction (HI) is among the most severe complications that can occur following the administration of intravenous recombinant tissue plasminogen activator (rt-PA). In the present study, we aimed to determine the optimal cut-off points of blood pressure (BP) for HI after rt-PA treatment, and to compare our findings with those for other prediction models.

Source: Journal of Stroke and Cerebrovascular Diseases - April 10, 2019 Category: Neurology Authors: Ryo Ohtani, Michikazu Nakamura, Shinsuke Nirengi, Osamu Kawakami, Jumpei Togawa, Kento Doi, Makoto Sainouchi, Yasuhiro Kuwata, Masaki Takata, Yuichi Masuda, Ryota Matsunari, Kiyoaki Takeda, Tetsuya Tsukahara, Naoki Sakane Source Type: research